![Jarrod Longcor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jarrod Longcor
Chief Operating Officer at
CELLECTAR BIOSCIENCES, INC.
Net worth: 32 048 $ as of 2026-08-30
Profile
Mr. Jarrod Longcor is a Chief Operating Officer at Cellectar Biosciences, Inc. Mr. Longcor was previously employed as a Chief Business Officer by Avillion LLP, a Vice President-Corporate Development by Melinta Therapeutics, Inc. /Old/, a Director-Business Development by MaxCyte, Inc., and a Senior Director-Business Development by Middlebrook Pharmaceuticals, Inc. He received his undergraduate degree from Dickinson College, a graduate degree from Boston University School of Medicine and an MBA from Erivan K.
Haub School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-06 | 12,768 ( 0.14% ) | 32 048 $ | 2026-08-30 |
Jarrod Longcor active positions
| Companies | Position | Start |
|---|---|---|
| CELLECTAR BIOSCIENCES, INC. | Chief Operating Officer | 2022-02-22 |
Former positions of Jarrod Longcor
| Companies | Position | End |
|---|---|---|
Avillion LLP
 Avillion LLP BiotechnologyHealth Technology Engages in clinical development of therapeutics | Corporate Officer/Principal | 2016-06-30 |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Corporate Officer/Principal | 2013-08-31 |
| MAXCYTE, INC. | Corporate Officer/Principal | - |
Middlebrook Pharmaceuticals, Inc.
 Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Corporate Officer/Principal | - |
Training of Jarrod Longcor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Middlebrook Pharmaceuticals, Inc.
Middlebrook Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pulsatile drug products | Health Technology |
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Dickinson College
 Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Avillion LLP
Avillion LLP BiotechnologyHealth Technology Engages in clinical development of therapeutics | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
Boston University School of Medicine
 Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erivan K. Haub School of Business
 Erivan K. Haub School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Jarrod Longcor
